Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Creams: SOP for Change Control Management in Cream Manufacturing – V 2.0

Posted on By

Creams: SOP for Change Control Management in Cream Manufacturing – V 2.0

Standard Operating Procedure for Change Control Management in Cream Manufacturing

Department Creams
SOP No. SOP/CRM/182/2025
Supersedes SOP/CRM/182/2022
Page No. Page 1 of 5
Issue Date 21/01/2026
Effective Date 26/01/2026
Review Date 21/01/2027

1. Purpose

The purpose of this SOP is to define the process for managing changes in the cream manufacturing process to ensure that all changes are documented, evaluated for impact, and approved to maintain product quality, safety, and compliance with GMP guidelines.

2. Scope

This SOP applies to all changes related to the cream manufacturing process, including but not limited to changes in raw materials, equipment, formulation, processing parameters, packaging, and testing methods.

3. Responsibilities

  • Production Team: Responsible for identifying and documenting any proposed changes during the manufacturing process and initiating the change control process.
  • Quality Control (QC) Team: Responsible for evaluating the impact of proposed changes on product quality and conducting any necessary testing to ensure the batch meets specifications.
  • Quality Assurance (QA) Team: Responsible for overseeing the change control process, approving or rejecting proposed changes, and ensuring that all changes are properly documented and compliant with regulatory requirements.
  • Regulatory Affairs: Responsible for ensuring that changes are evaluated for regulatory
impact and compliance with applicable laws and guidelines.

4. Accountability

The Production Manager is accountable for initiating the change control process and ensuring that the production team follows the proper procedures. The QC Manager is responsible for evaluating the impact on product quality, while the QA Manager is responsible for final approval and ensuring compliance with this SOP.

5. Procedure

5.1 Initiating a Change Request

  1. Any proposed change to the manufacturing process, materials, equipment, or testing methods must be documented in a Change Request Form (Annexure-1).
  2. The Change Request Form should include the following details:
    • Description of the proposed change
    • Reason for the change
    • Potential impact on product quality, safety, and compliance
    • Proposed timeline for implementation
    • Responsible parties for implementing the change
  3. The Production Team must submit the Change Request Form to the QA team for evaluation.

5.2 Evaluating the Change

  1. The QA team reviews the Change Request Form and evaluates the potential impact of the proposed change on product quality, safety, and regulatory compliance.
  2. QC must conduct any required testing, such as stability tests or microbial testing, to assess the impact of the change on the cream product.
  3. If the proposed change could potentially affect the final product’s specifications, a risk assessment must be conducted, and additional validation or qualification steps may be required.
  4. If the change affects regulatory compliance (e.g., packaging changes, formulation alterations), Regulatory Affairs must assess the change for regulatory impact and update relevant documentation as necessary.

5.3 Approving the Change

  1. If the proposed change is deemed acceptable by the QA, QC, and Regulatory Affairs teams, the QA Manager approves the change and issues a Change Control Approval Form (Annexure-2).
  2. The QA Manager also ensures that any necessary training or procedure updates are completed before the change is implemented.
  3. If the change is not approved, the Change Request Form is returned to the Production Team with a request for further clarification or revision. The reason for rejection must be documented.

5.4 Implementing the Change

  1. Once the change is approved, the Production Team is responsible for implementing the change according to the defined procedure or timeline.
  2. Ensure that all affected documentation, including Batch Manufacturing Records (BMR) and Standard Operating Procedures (SOPs), are updated to reflect the change.
  3. Conduct any necessary re-validation or re-qualification of equipment, processes, or materials affected by the change.
  4. The change must be communicated to all relevant departments, including Production, QC, and Regulatory Affairs, to ensure consistency and compliance.

5.5 Monitoring and Reviewing the Change

  1. After the change is implemented, monitor the affected process for any issues that may arise, including unexpected results or deviations from specifications.
  2. If any issues are detected, initiate a deviation report (Annexure-3) and investigate the cause of the problem.
  3. Review the effectiveness of the change after a defined period to ensure that the change has achieved the intended outcome and that no adverse effects have been observed in production or product quality.

5.6 Documentation and Record-Keeping

  1. Ensure that all Change Request Forms, Change Control Approval Forms, deviation reports, and validation records are properly documented and stored for audit purposes.
  2. All records related to the change control process must be retained for at least two years or as per regulatory requirements.
  3. Ensure that all changes are tracked in the Change Control Log (Annexure-4) for traceability and accountability.

6. Abbreviations

  • GMP: Good Manufacturing Practices
  • QC: Quality Control
  • QA: Quality Assurance
  • PPE: Personal Protective Equipment
  • BMR: Batch Manufacturing Record
  • SOP: Standard Operating Procedure
  • CAPA: Corrective and Preventive Action

7. Documents

  1. Annexure-1: Change Request Form
  2. Annexure-2: Change Control Approval Form
  3. Annexure-3: Deviation Report
  4. Annexure-4: Change Control Log

8. References

  • Good Manufacturing Practices (GMP) Guidelines – 21 CFR Part 211
  • International Conference on Harmonisation (ICH) Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
  • FDA Guidance for Industry: Change Control in Pharmaceutical Manufacturing

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Change Request Form

Change Description Reason for Change Impact Assessment Proposed Timeline Responsible Parties
Change in raw material supplier New supplier offering better price No impact on product quality 15/02/2026 Production, QA

Annexure-2: Change Control Approval Form

Change Number Approval Date Approved By Remarks
001 26/01/2026 QA Head Approved for implementation

Annexure-3: Deviation Report

Deviation Description Corrective Action Taken Resolved By Resolution Date
Delay in raw material delivery Rescheduled production, updated supplier lead time Procurement Manager 22/01/2026

Annexure-4: Change Control Log

Change Number Change Description Status Approval Date Implemented By
001 Change in raw material supplier Approved 26/01/2026 Production Team

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/03/2024 1.0 Initial Version New SOP Creation QA Head
01/03/2025 2.0 Format Revision and Updates Standardization of Document QA Head
See also  Creams: SOP for Conducting FTIR Analysis of Cream Ingredients - V 2.0
Creams V 2.0 Tags:Batch record documentation for creams, Change control procedures for cream manufacturing, Cleaning and sanitization SOPs in creams production, Complaint handling SOPs in creams production, Continuous improvement SOPs for cream manufacturing, Cream manufacturing process guidelines, Creams production documentation practices, Deviation handling SOPs in creams production, Employee training SOPs in creams manufacturing, Environmental monitoring SOPs in creams manufacturing, Equipment calibration SOPs for cream manufacturing, GMP compliance in creams production, Internal audit procedures in creams production, Packaging and labeling SOPs for creams, Pharmaceutical SOPs, Product quality review procedures for creams, Product release criteria SOPs for creams, Quality control SOPs for creams, ream manufacturing SOP, Regulatory requirements for cream production SOPs, Risk management SOPs in creams manufacturing, Stability testing SOPs for cream products, Standard operating procedures for skincare products, Supplier qualification SOPs for cream ingredients, Validation protocols for cream production processes

Post navigation

Previous Post: Analytical Method Development: BET Method Development (Bacterial Endotoxins Test) – V 2.0
Next Post: BA-BE Studies: SOP for Documentation of Sample Storage Conditions – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version